“Tesamorelin reduces visceral fat in adults with HIV-associated lipodystrophy.”

Supported with scope

The reviewed evidence supports this exact statement only in the situation described below.

Phase 3 trials and the product label support this outcome in the labeled population.

What this answer is based on

This answer uses a study that assigned people to groups by chance and measured a health outcome.

Limits of this answer

Adults with HIV and excess abdominal fat meeting the trial and label criteria. These limits show which substance, product, people, use, place, and time the answer covers. A different product or situation can have a different answer.

Topic

What research measured about body fat, lean mass, or related body changes.